(Press-News.org) San Diego – Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of previously reported six-month outcomes from APOLLO, the Company's European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction (heart attack or AMI), as Research Correspondence in the Journal of the American College of Cardiology. The APOLLO trial was a 14-patient, prospective, randomized, double-blind, placebo-controlled, feasibility trial (Phase I/IIA) evaluating autologous ADRCs extracted with the Company's proprietary Celution® System for the treatment of patients suffering from acute myocardial infarction.
In the APOLLO trial all patients were treated with standard-of-care and subsequently underwent an abdominal liposuction. Each patient's adipose tissue was processed by the Celution® System where ADRCs were extracted, washed and concentrated into a syringe of clinical grade cells. Within 36 hours of the myocardial infarction and no longer than 24 hours after undergoing percutaneous coronary intervention, patients received an injection of either 20 million ADRCs (n=10) or a placebo (n=4).
The publication reported:
Safety
The procedure could be safely performed in an acute setting
No side effects from ADRC delivery, processed using Celution®
No increase in arrhythmias
Feasibility
Improvement in cardiac function by SPECT
Improvement in blood flow into the heart muscle (perfusion defect)
Reduction in scar formation (infarct size)
"Based on both the six and 18-month outcomes, which showed continued safety and sustained long-term benefits, we initiated ADVANCE, a pivotal, prospective, randomized, double-blind, European heart attack trial in up to 360 patients," said Christopher J. Calhoun, CEO for Cytori. "The goal of our ADRC therapy is to reduce scarring, preserve heart muscle beyond what can be salvaged with current treatments, minimize harmful remodeling, and ultimately protect patients from advancing into heart failure."
The publication, co-authored by trial investigators Drs. Henricus J. Duckers, Patrick W. Serruys, Jaco H. Houtgraaf at Thoraxcenter, Erasmus University Hospital and others, reported the following:
The percentage of left ventricle (LV) infarcted was reduced by 52% (31.6 ± 5.3% to 15.3 ± 2.6% at six-month follow-up, p=0.002) in the ADRC-treated patients, as opposed to no change in the placebo-treated AMI patients (24.7 ± 9.2 % vs. 24.7 ± 4.1%). The difference between the groups was not statistically significant.
There was a significant improvement of the perfusion defect in ADRC-treated patients from 16.9 ± 2.1% to 10.9 ± 2.4% at six-month follow-up (change of 6.0%, p=0.004) as compared to a deterioration in the placebo group by 1.8% (15.0 ± 4.9% to 16.8 ± 4.3%).
Left ventricular ejection fraction (LVEF), measured by SPECT, improved with an absolute difference of +5.7% (p=0.114). In ADRC treated patients, LVEF improved by 4% (52.1% to 56.1%), as compared to a deterioration of 1.7% in the placebo group (52.0% to 50.3%).
"The advantage of adipose tissue as a cell source is that it allows physicians to get a meaningful dose of a patient's own cells at the point-of-care when using the Celution® System without cell culture or use of donor cells," said Dr. Duckers, lead author of the paper. "We believe delivering cells within the first 24 to 36 hours takes advantage of the body's signaling and initiates the repair process before irreparable damage occurs."
Cytori is currently preparing the full 18 month data set for publication.
INFORMATION:
About Cytori
Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft® products are available in North America and Europe for fat grafting procedures. www.cytori.com
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements regarding events, trends, business prospects and particularly relating to mechanisms and effectiveness of our ADRC therapy and our APOLLO and ADVANCE clinical trial, which may affect our future operating results and financial position. Such statements, including, but not limited to, those regarding improvements in patient outcomes, the significance of the physiological and functional effects from the pilot APOLLO trial, and the mechanisms and effectiveness of the design of the ADVANCE trial, are all subject to risks and uncertainties that could cause the results of the more comprehensive ADVANCE trial to differ materially from those presented above. Some of these risks and uncertainties include, but are not limited to, risks related to the statistical power of the APOLLO trial, the inherent risk and uncertainty in the costs and potential variability of outcomes of a pivotal heart attack trial, uncertainties regarding the collection and results of clinical data, and dependence on third party performance, as well as other risks and uncertainties described under the "Risk Factors" in Cytori's Securities and Exchange Commission Filings on Form 10-K and Form 10-Q. We assume no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made.
END
A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine.
The cholesterol receptor offers a promising new target for anti-viral therapy, for which an approved drug may already exist, say the researchers, whose findings were reported online in advance of publication in Nature Medicine.
An estimated 4.1 million Americans are infected with hepatitis C virus, or HCV, which ...
RIVERSIDE, Calif. – In August 2010, an entomologist at the University of California, Riverside discovered a tiny fairyfly wasp in upstate New York that had never been seen in the United States until then. Nearly exactly a year later, he discovered the wasp in Irvine, Calif., strongly suggesting that the wasp is well established in the country.
Called Gonatocerus ater, the wasp is about 1 millimeter long and arrived in North America from Europe. It lays its eggs inside the eggs of leafhoppers.
Leafhopper females lay their eggs inside plant tissue. Gonatocerus ater ...
Hampton Inn Atlanta-Southlake Morrow GA Hotel offers affordable accommodations to participants and guests attending the Metropolitan Opera National Council auditions. Taking place at Clayton State University's Spivey Hall, the auditions will be held on Sunday, February 5, 2012. At the event, outstanding young vocalists from North Carolina, South Carolina, Florida, and Georgia will sing opera arias before a panel of expert judges, competing to advance to the national finals on stage at the Metropolitan Opera in New York. Tickets are $35 and can be purchased through Spivey ...
Sheraton Atlanta Perimeter North / Dunwoody Hotel, located at Atlanta Perimeter Center, announces a new special savings package for travelers to enjoy. Guests who register for the SPG Better by the Night promotion can earn unlimited bonus Starpoints even faster. With every stay from January 9 through April 8, 2012, at this property and over 750 other participating hotels and resorts worldwide, guests earn double Starpoints on two-night stays and triple Starpoints on stays of three nights or longer.
Register by March 15, 2012, and then book your stays to begin earning ...
Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease. The study showed a close association with two conditions in particular: high blood pressure and elevated fasting blood sugar levels, which is a precursor to diabetes. The research is published today in the medical research journal Translational Psychiatry.
"This is the first report of an underlying ...
RIVERSIDE, Calif. – A research team led by physicists at the University of California, Riverside has identified a property of "bilayer graphene" (BLG) that the researchers say is analogous to finding the Higgs boson in particle physics.
Graphene, nature's thinnest elastic material, is a one-atom thick sheet of carbon atoms arranged in a hexagonal lattice. Because of graphene's planar and chicken wire-like structure, sheets of it lend themselves well to stacking.
BLG is formed when two graphene sheets are stacked in a special manner. Like graphene, BLG has high current-carrying ...
COLUMBUS, Ohio – On any given weekend, at least 10 percent of students at a single college could be hosting a party, and on average, party hosts who live off campus are drinking more and engaging in more alcohol-related problem behaviors than are the students attending their bashes, research suggests.
In contrast, hosts of parties held on campus tend to drink less than do the students attending their gatherings, according to the study.
The research also suggests that college party hosts are more likely than the students attending parties to be male, living off campus, ...
Santa Barbara, CA –The Bren School-based authors of a study published Jan. 20 in the journal PLoS ONE have observed toxicity to marine organisms resulting from exposure to a nanoparticle that had not previously been shown to be toxic under similar conditions.
Lead author and assistant research biologist Robert Miller and co-authors Arturo Keller and Hunter Lenihan – both Bren School professors and lead scientists at the UC Center for Environmental Implications of Nanotechnology (UC CEIN) – Bren Phd student Samuel Bennett, and Scott Pease, a former UCSB undergraduate ...
The fate of the world's great whale species commands global attention as a result of heated debate between pro and anti-whaling advocates, but the fate of smaller marine mammals is less understood, specifically because the deliberate and accidental catching and killing of dolphins, porpoises, manatees, and other warm-blooded aquatic species are rarely studied or monitored.
To shed more light on the issue, researchers from the Wildlife Conservation Society and Okapi Wildlife Associates have conducted an exhaustive global study of human consumption of marine mammals using ...
HOUSTON -- Rice University physicists have gone to extremes to prove that Isaac Newton's classical laws of motion can apply in the atomic world: They've built an accurate model of part of the solar system inside a single atom of potassium.
In a new paper published this week in Physical Review Letters, Rice's team and collaborators at the Oak Ridge National Laboratory and the Vienna University of Technology showed they could cause an electron in an atom to orbit the nucleus in precisely the same way that Jupiter's Trojan asteroids orbit the sun.
The findings uphold a ...
